Why the study?
Dyslipidemia is a critical risk factor for cardiovascular disease, making the evaluation of trends in lipid profiles essential for developing health policies and programs.
What are the secular trends in lipid profiles and lipid-lowering medication use among Korean adults over an 11-year period?
What are the secular trends in lipid profiles and lipid-lowering medication use among Korean adults over an 11-year period?
Despite increased use of lipid-lowering medications, total cholesterol levels are rising among Korean adults not on therapy, highlighting the need for continued public health interventions.
Rising TC among untreated adults signals prevention gaps; leaves open drivers of secular trends and optimal responses.
Dyslipidemia is a primary, critical risk factor for cardiovascular disease. Therefore, evaluating the trends in lipid profiles is crucial for the development of health policies and programs. We studied trends in lipid profiles in Korean adults over an 11-year period according to the use of lipid-lowering medications through age-specific analysis. A total of 73,890 participants were included in the Korean National Health and Nutrition Examination Survey III (2005)-VI (2013-2015). The proportion of participants on lipid-lowering medications has increased. This trend was apparent in age groups of over 40 years in both men and women. Lipid-lowering medications successfully reduced mean total cholesterol (TC), but there was no favorable trend in TC in participants not taking lipid-lowering medication in both men and women. Unlike men, triglyceride and non-high-density lipoprotein cholesterol (HDL) decreased in women without lipid-lowering medications. In age-specific hypercholesterolemia, the prevalence of hypercholesterolemia significantly increased in the age groups of 30-59 and 30-49 years in men and women without lipid-lowering medications, respectively. Meanwhile, mean HDL-C levels increased over the 11-year period regardless of lipid-lowering drug use in both men and women. These analyses identified an upward trend in TC and HDL-C over the 11-year period.
No takes yet. Share an insight, caveat, or question.
Kwon et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: